SEC Form D · Amendment · filed December 21, 2020
Enalare Therapeutics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Daniel Motto · Princeton, NJExecRobert Yedid · Princeton, NJDirectorGino Santini · Princeton, NJDirectorHerman Cukier · Princeton, NJExec · DirectorJoseph Pergolizzi · Naples, FLExec · DirectorJoseph Petko · Princeton, NJDirectorScott Cohen · Brooklyn, NYExecBrenden M. Smith · Mill Valley, CAExec · DirectorAnthony Morena · NY, NYDirectorAlana Palmedo · San Francisco, CADirectorReena Jashnani-Slusarz · San Francisco, CAExec · DirectorKhalid Naeem · Vancouver, British Columbia, CanadaDirectorPatrick Duncan · Charleston, SCDirectorDavid B. Rendina · Jupiter, FLExec · DirectorHaitham Al-Beik · MARLBOROUGH, MAExec · DirectorHari Rao · MARLBOROUGH, MADirectorGreg Litvak · Denver, COExecDaniel Zinn · Santa Monica, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗